Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Envveno Medical Corp (NVNO)

Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,694
  • Shares Outstanding, K 20,216
  • Annual Sales, $ 0 K
  • Annual Income, $ -21,820 K
  • EBIT $ -24 M
  • EBITDA $ -23 M
  • 60-Month Beta 1.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.25
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.08
  • Most Recent Earnings $-0.23 on 10/31/25
  • Next Earnings Date 02/26/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Options Overview Details

View History
  • Implied Volatility 510.40% (-34.50%)
  • Historical Volatility 100.11%
  • IV Percentile 92%
  • IV Rank 47.89%
  • IV High 1,006.22% on 12/08/25
  • IV Low 54.81% on 04/14/25
  • Expected Move (DTE 17) 1.9210 (573.60%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 12,865
  • Open Int (30-Day) 12,952
  • Expected Range 0.0000 to 2.2559

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +333,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3011 +12.09%
on 12/15/25
0.4190 -19.45%
on 12/01/25
-0.0460 (-11.99%)
since 11/28/25
3-Month
0.3011 +12.09%
on 12/15/25
1.0050 -66.42%
on 10/08/25
-0.5686 (-62.75%)
since 09/30/25
52-Week
0.3011 +12.09%
on 12/15/25
5.6200 -93.99%
on 07/17/25
-2.6925 (-88.86%)
since 12/30/24

Most Recent Stories

More News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment

Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Wednesday, December 3rd at 4:00 PM ET

NVNO : 0.3346 (+1.06%)
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve

IRVINE, CA / ACCESS Newswire / November 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease,...

NVNO : 0.3346 (+1.06%)
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update

- Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and the enVVe IDE study

NVNO : 0.3346 (+1.06%)
enVVeno Medical Faces Nasdaq Delisting Notice

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. enVVeno Medical...

NVNO : 0.3346 (+1.06%)
enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment

Watch the "What This Means" video here

NVNO : 0.3346 (+1.06%)
enVVeno Medical Updates Regulatory Status of VenoValve(R)

IRVINE, CA / ACCESS Newswire / September 15, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease,...

NVNO : 0.3346 (+1.06%)
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)

IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease,...

NVNO : 0.3346 (+1.06%)
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025

Register for the three-day event here

AKTX : 0.2595 (-0.76%)
NUWE : 1.7375 (-4.53%)
AIM : 1.2200 (-7.40%)
AMIX : 0.6280 (+17.30%)
SNTI : 1.0650 (+0.47%)
CNSP : 5.46 (+2.82%)
NVNO : 0.3346 (+1.06%)
MBRX : 3.21 (-6.83%)
GRI : 0.2814 (+13.51%)
enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

- Live webcast on Thursday, August 21stat 2:00 PM ET

NVNO : 0.3346 (+1.06%)
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency

Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatments

NVNO : 0.3346 (+1.06%)

Business Summary

enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.

See More

Key Turning Points

3rd Resistance Point 0.3712
2nd Resistance Point 0.3632
1st Resistance Point 0.3471
Last Price 0.3346
1st Support Level 0.3230
2nd Support Level 0.3150
3rd Support Level 0.2989

See More

52-Week High 5.6200
Fibonacci 61.8% 3.5882
Fibonacci 50% 2.9605
Fibonacci 38.2% 2.3329
Last Price 0.3346
52-Week Low 0.3011

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar